DXCM vs PLUR · P/E 63, rev $2.50B vs rev $1.3M
DexCom Inc (DXCM) versus Pluri Inc. (PLUR) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Pluri Inc. (PLUR) is a biotechnology company listed on NASDAQ.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported PLUR revenue for 2025-06-30 was $1.3M. Net income was -$23.3M. PLUR currently screens at market cap $24.3M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. PLUR currently screens at market cap $24.3M.
Not investment advice. Open the DXCM and PLUR stock pages for the full models.
Not investment advice.